Forcyte Biotechnologies Revenue and Competitors

Forcyte Biotechnologies is putting the Focus On Force in disease. As mechanical force underlies important processes in all cells, it is a key functional component driving various diseases - (asthma, hypertension, preterm labor, intestinal dysmotility, many others). Forcyte is commercializing the (UCLA-developed) FLECS Technology Platform for high-throughput analysis of contractile cell force. We develop assays, build hardware, supply software, and perform services to functionally characterize cellular force in high-throughput, down to the single-cell level! Our mission is to: 1) enable the budding field of \Force Biology\ to automate their data collection in a standardized format to allow for direct comparison between studies, and to ultimately remove the barriers to entry for all researchers 2) provide functional high-throughput data on cellular force to support drug development in pharma, including phenotypic drug discovery, functional quantification / dose-response, toxicology, off-target effects, and general confirmation that desired contractile function is ultimately achieved See our website for more info!